WUHN Stock Chart & Stats
<$0.01
$0.00(0.00%)
At close: 4:00 PM EDT
<$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.01 - $0.01
Previous CloseN/A
Volume155.00
Average Volume (3M)N/A
Market Cap
$14.42K
Enterprise Value-$7.23K
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$86.79K
Price to Earnings (P/E)―
Beta-19.10
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.14
Shares Outstanding48,055,160
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)61.75
Price to Sales (P/S)2514.97
P/FCF Ratio-21.47
Enterprise Value/Market Cap-0.50
Enterprise Value/Revenue-1.58
Enterprise Value/Gross Profit-3.48
Enterprise Value/Ebitda<0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
WUHN FAQ
What was Wuhan General Group [China]’s price range in the past 12 months?
Wuhan General Group [China] lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.
What is Wuhan General Group [China]’s market cap?
Wuhan General Group [China]’s market cap is $14.42K.
When is Wuhan General Group [China]’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Wuhan General Group [China]’s earnings last quarter?
Wuhan General Group [China] released its earnings results on May 20, 2021. The company reported -$0.008 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.008.
Is Wuhan General Group [China] overvalued?
According to Wall Street analysts Wuhan General Group [China]’s price is currently Overvalued.
Does Wuhan General Group [China] pay dividends?
Wuhan General Group [China] does not currently pay dividends.
What is Wuhan General Group [China]’s EPS estimate?
Wuhan General Group [China]’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Wuhan General Group [China] have?
Wuhan General Group [China] has 48,055,160 shares outstanding.
What happened to Wuhan General Group [China]’s price movement after its last earnings report?
Wuhan General Group [China] reported an EPS of -$0.008 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Wuhan General Group [China]?
Currently, no hedge funds are holding shares in WUHN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Wuhan General Group [China]
Wuhan General Group (China), Inc. is a nutraceutical biotechnology company, which engages in the development of alternative plant-based cannabinoids and psilocybin medical research that commercializes a range of cannabidiol and mushrooms-based products under the Dr. AnnaRx, Medspresso and Handcrafted Delights brands. The firm is also engages in research and development of indications for psilocybin new therapies that will help patients who suffer from mental illness, Alzheimer's and Parkinson's. The company was founded by Xu Jie and Jeff Robinson on July 19, 1988 and is headquartered in Cape Town, South Africa.